US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

5.47

+0.14002.63%

Post-market: 5.470.00000.00%19:37 EDT

Volume:38.31K

Turnover:206.90K

Market Cap:5.20M

PE:-0.11

High:6.00

Open:5.18

Low:5.02

Close:5.33

52wk High:20.99

52wk Low:3.82

Shares:950.30K

Float Shares:832.40K

Volume Ratio:1.37

T/O Rate:4.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-49.8904

EPS(LYR):-52.5900

ROE:-52.14%

ROA:-17.13%

PB:4.15

PE(LYR):-0.10

Loading ...

Overview Company News Filings

TransCode Says Phase 1a Cancer Trial Meets Safety Goal, Advances Drug to Phase 2a

MT Newswires Live

TransCode Therapeutics reports Phase 1a trial of TTX-MC138 meets safety endpoint in metastatic cancer

Transcode Therapeutics - Ttx-Mc138 Advances to Phase 2a Clinical Development in Ctdna-Positive Colorectal Cancer

THOMSON REUTERS

Transcode Therapeutics - Phase 1a Trial Meets Safety Endpoint With No Dose-Limiting Toxicities

THOMSON REUTERS

Transcode Therapeutics - Recommended Phase 2a Dose for Ttx-Mc138 Set at 4.8Mg/Kg

THOMSON REUTERS

EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study

Benzinga_recent_news

TransCode Sets Key Deadlines for 2026 Shareholder Meeting

TransCode Therapeutics sets 2026 annual shareholder meeting

Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138

TransCode Therapeutics launches Phase 2a trial of TTX-MC138 in ctDNA-positive colorectal cancer patients

Transcode Therapeutics Initiates Phase 2a Clinical Trial With Ttx-Mc138 in Patients With Ctdna Positive Colorectal Cancer

THOMSON REUTERS

TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice

TransCode Therapeutics falls short of Nasdaq $2.5 million stockholders' equity requirement

TransCode Therapeutics Q1 EPS $(21.28) Up From $(70.16) YoY

TransCode Therapeutics Q1 FY26 net loss widens to $17.79 million

TransCode Therapeutics announces virtual special shareholder meeting

TransCode Registers 1.53 Million Shares for YA II PN Resale Under Equity Purchase Deal

MT Newswires Live

Transcode Therapeutics files to sell 15.96M shares of common stock for holders

Transcode Therapeutics - Files for Resale of up to About 16 Mln Common Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS

Transcode Therapeutics Appoints DR. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement With Michigan State University

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNAZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNAZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":5.47,"timestamp":1781553600000,"preClose":5.33,"halted":0,"volume":38308,"hourTrading":{"tag":"盘后","latestPrice":5.47,"preClose":5.47,"latestTime":"19:37 EDT","volume":33,"amount":194.46,"timestamp":1781566640041,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02626641651031889,"floatShares":832400,"shares":950300,"eps":-49.890354,"marketStatus":"Closed","change":0.14,"latestTime":"06-15 16:00:00 EDT","open":5.175,"high":6,"low":5.02,"amount":206903.0249968,"amplitude":0.183865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-49.890354,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781596800000},"marketStatusCode":5,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":5.33,"preHourTrading":{"tag":"盘前","latestPrice":5.5,"preClose":5.33,"latestTime":"09:17 EDT","volume":76,"amount":417.62,"timestamp":1781529449362,"change":0.17,"changeRate":0.031895,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.47,"preClose":5.47,"latestTime":"19:37 EDT","volume":33,"amount":194.46,"timestamp":1781566640041,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.36785},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","floatShares":832400,"roa":"-17.13%","roe":"-52.14%","lyrEps":-52.59,"volumeRatio":1.36785,"shares":950300,"dividePrice":0,"high":6,"amplitude":0.183865,"preClose":5.33,"low":5.02,"week52Low":3.82,"pbRate":"4.15","week52High":20.99,"institutionHeld":0,"latestPrice":5.47,"eps":-49.890354,"divideRate":0,"volume":38308,"delay":0,"ttmEps":-49.890354,"open":5.175,"prevYearClose":6.83,"prevWeekClose":5.33,"prevMonthClose":5.14,"prevQuarterClose":8.61,"fiveDayClose":5.09,"twentyDayClose":6.6,"sixtyDayClose":9.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"RNAZ","defaultRemindTime":1747315800000,"type":"split","dateTimestamp":1747281600000,"forFactor":28,"toFactor":1,"ratio":28},{"market":"US","date":"2024-12-04","symbol":"RNAZ","defaultRemindTime":1733322600000,"type":"split","dateTimestamp":1733288400000,"forFactor":33,"toFactor":1,"ratio":33},{"market":"US","date":"2024-01-16","symbol":"RNAZ","defaultRemindTime":1705415400000,"type":"split","dateTimestamp":1705381200000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-05-23","symbol":"RNAZ","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2021-08-23","symbol":"RNAZ","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629691200000,"reportTimeType":"","actualEps":0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAZ","date":"2026-06-12","current":-0.10964,"percent":0.926809,"low":-13.297156,"twenty":-3.282089,"median":-0.364324,"eighty":-0.230493,"high":-0.024019,"avg":-1.746133,"sd":2.744796,"marketCap":5407218},"quantilePoints":[{"date":"2021-06-18","current":-2.6923,"twenty":-14.365299,"median":-14.365299,"eighty":-4.960352,"marketCap":18275252},{"date":"2021-06-22","current":-7.012211,"twenty":-14.365299,"median":-14.365299,"eighty":-5.781096,"marketCap":47598684},{"date":"2021-07-09","current":-9.273649,"twenty":-14.365299,"median":-14.365299,"eighty":-7.012211,"marketCap":62949259},{"date":"2021-07-16","current":-5.64483,"twenty":-14.365299,"median":-10.29042,"eighty":-6.205807,"marketCap":38316940},{"date":"2021-07-23","current":-5.942849,"twenty":-14.365299,"median":-7.012211,"eighty":-5.416933,"marketCap":40339884},{"date":"2021-07-30","current":-5.101383,"twenty":-14.365299,"median":-7.012211,"eighty":-5.101383,"marketCap":34628042},{"date":"2021-08-06","current":-5.574708,"twenty":-14.365299,"median":-6.205807,"eighty":-5.136444,"marketCap":37840953},{"date":"2021-08-13","current":-5.031261,"twenty":-14.365299,"median":-5.811369,"eighty":-5.136444,"marketCap":34152055},{"date":"2021-08-20","current":-4.768303,"twenty":-14.365299,"median":-5.714952,"eighty":-5.066322,"marketCap":32367105},{"date":"2021-08-27","current":-10.254026,"twenty":-14.365299,"median":-5.811369,"eighty":-5.083853,"marketCap":39886816},{"date":"2021-09-03","current":-8.929933,"twenty":-11.30719,"median":-6.205807,"eighty":-5.09963,"marketCap":34736270},{"date":"2021-09-10","current":-9.261701,"twenty":-10.464659,"median":-7.012211,"eighty":-5.101032,"marketCap":36026802},{"date":"2021-09-17","current":-8.037833,"twenty":-10.121716,"median":-7.012211,"eighty":-5.129432,"marketCap":31266117},{"date":"2021-09-24","current":-12.106366,"twenty":-10.464659,"median":-7.99392,"eighty":-5.178518,"marketCap":47092176},{"date":"2021-10-01","current":-9.460165,"twenty":-10.702816,"median":-8.236298,"eighty":-5.217085,"marketCap":36798804},{"date":"2021-10-08","current":-9.096313,"twenty":-10.445875,"median":-8.533995,"eighty":-5.308243,"marketCap":35383466},{"date":"2021-10-15","current":-10.650956,"twenty":-10.598032,"median":-8.782076,"eighty":-5.399402,"marketCap":41430822},{"date":"2021-10-22","current":-9.096313,"twenty":-10.598032,"median":-9.096313,"eighty":-5.459006,"marketCap":35383466},{"date":"2021-10-29","current":-9.360933,"twenty":-10.558339,"median":-9.12939,"eighty":-5.483549,"marketCap":36412803},{"date":"2021-11-05","current":-10.849421,"twenty":-10.750188,"median":-9.228623,"eighty":-5.543153,"marketCap":42202825},{"date":"2021-11-12","current":-9.757863,"twenty":-10.750188,"median":-9.261701,"eighty":-5.557177,"marketCap":37956809},{"date":"2021-11-19","current":-7.259636,"twenty":-10.670802,"median":-9.228623,"eighty":-5.571202,"marketCap":35177810},{"date":"2021-11-26","current":-7.153268,"twenty":-10.611263,"median":-9.162468,"eighty":-5.616781,"marketCap":34662385},{"date":"2021-12-03","current":-7.17986,"twenty":-10.564954,"median":-9.096313,"eighty":-5.686903,"marketCap":34791241},{"date":"2021-12-10","current":-7.153268,"twenty":-10.472337,"median":-8.831693,"eighty":-5.735989,"marketCap":34662385},{"date":"2021-12-17","current":-6.860756,"twenty":-10.419413,"median":-8.60015,"eighty":-5.781568,"marketCap":33244964},{"date":"2021-12-23","current":-7.126676,"twenty":-10.353258,"median":-8.451301,"eighty":-5.809616,"marketCap":34533528},{"date":"2021-12-31","current":-6.754387,"twenty":-10.227564,"median":-8.037833,"eighty":-5.869221,"marketCap":32729538},{"date":"2022-01-07","current":-6.461874,"twenty":-10.148178,"median":-7.959179,"eighty":-6.048032,"marketCap":31312117},{"date":"2022-01-14","current":-6.674611,"twenty":-10.075407,"median":-7.764886,"eighty":-6.28696,"marketCap":32342968},{"date":"2022-01-21","current":-5.398191,"twenty":-10.035714,"median":-7.658518,"eighty":-5.961559,"marketCap":26157859},{"date":"2022-01-28","current":-6.036401,"twenty":-9.943097,"median":-7.405893,"eighty":-5.890049,"marketCap":29250414},{"date":"2022-02-04","current":-6.435282,"twenty":-9.890173,"median":-7.259636,"eighty":-5.961559,"marketCap":31183260},{"date":"2022-02-11","current":-5.517856,"twenty":-9.883557,"median":-7.233044,"eighty":-5.961559,"marketCap":26737713},{"date":"2022-02-18","current":-5.850257,"twenty":-9.85048,"median":-7.17986,"eighty":-5.855575,"marketCap":28348419},{"date":"2022-02-25","current":-5.797072,"twenty":-9.824018,"median":-7.17986,"eighty":-5.802604,"marketCap":28090706},{"date":"2022-03-04","current":-5.956625,"twenty":-9.824018,"median":-7.139972,"eighty":-5.750013,"marketCap":28863844},{"date":"2022-03-11","current":-6.328914,"twenty":-9.757863,"median":-7.012211,"eighty":-5.750013,"marketCap":30667835},{"date":"2022-03-18","current":-6.780979,"twenty":-9.757863,"median":-7.012211,"eighty":-5.743888,"marketCap":32858394},{"date":"2022-03-25","current":-6.54165,"twenty":-9.757863,"median":-6.91394,"eighty":-5.750013,"marketCap":31698686},{"date":"2022-04-01","current":-5.336521,"twenty":-9.757863,"median":-6.953828,"eighty":-5.743888,"marketCap":36519944},{"date":"2022-04-08","current":-5.713661,"twenty":-9.757863,"median":-6.91394,"eighty":-5.690704,"marketCap":39100859},{"date":"2022-04-14","current":-5.406292,"twenty":-9.757863,"median":-6.887347,"eighty":-5.660256,"marketCap":36997413},{"date":"2022-04-22","current":-5.072524,"twenty":-9.704939,"median":-6.840812,"eighty":-5.571315,"marketCap":34713304},{"date":"2022-04-29","current":-5.147952,"twenty":-9.58586,"median":-6.780979,"eighty":-5.549313,"marketCap":35229487},{"date":"2022-05-06","current":-5.214864,"twenty":-9.480012,"median":-6.767683,"eighty":-5.483549,"marketCap":35687393},{"date":"2022-05-13","current":-4.266707,"twenty":-9.460165,"median":-6.754387,"eighty":-5.429601,"marketCap":29198776},{"date":"2022-05-20","current":-4.475575,"twenty":-9.407241,"median":-6.674611,"eighty":-5.404672,"marketCap":26084240},{"date":"2022-05-27","current":-4.074778,"twenty":-9.39401,"median":-6.674611,"eighty":-5.336521,"marketCap":23748338},{"date":"2022-06-03","current":-3.941178,"twenty":-9.374164,"median":-6.621427,"eighty":-5.324634,"marketCap":22969704},{"date":"2022-06-10","current":-3.629447,"twenty":-9.360933,"median":-6.54165,"eighty":-5.272407,"marketCap":21152891},{"date":"2022-06-17","current":-2.671985,"twenty":-9.308563,"median":-6.488466,"eighty":-5.22381,"marketCap":15572680},{"date":"2022-06-24","current":-2.850118,"twenty":-9.26887,"median":-6.461874,"eighty":-5.199367,"marketCap":16610859},{"date":"2022-07-01","current":-2.761052,"twenty":-9.261701,"median":-6.435282,"eighty":-5.137471,"marketCap":16091770},{"date":"2022-07-08","current":-3.094827,"twenty":-9.261701,"median":-6.40869,"eighty":-5.087008,"marketCap":18037057},{"date":"2022-07-15","current":-2.939184,"twenty":-9.261701,"median":-6.328914,"eighty":-4.996097,"marketCap":17129948},{"date":"2022-07-22","current":-2.872384,"twenty":-9.255085,"median":-6.227473,"eighty":-4.960352,"marketCap":16740631},{"date":"2022-07-29","current":-3.161849,"twenty":-9.222007,"median":-6.116177,"eighty":-4.771809,"marketCap":18427672},{"date":"2022-08-05","current":-3.195249,"twenty":-9.18893,"median":-6.116177,"eighty":-4.618082,"marketCap":18622330},{"date":"2022-08-12","current":-2.872384,"twenty":-9.149237,"median":-6.036401,"eighty":-4.456649,"marketCap":16740631},{"date":"2022-08-19","current":-1.241956,"twenty":-9.096313,"median":-6.023105,"eighty":-4.180624,"marketCap":16481087},{"date":"2022-08-26","current":-1.095268,"twenty":-9.096313,"median":-5.942849,"eighty":-4.079231,"marketCap":14534502},{"date":"2022-09-02","current":-1.163722,"twenty":-9.063037,"median":-5.890145,"eighty":-3.972352,"marketCap":15442908},{"date":"2022-09-09","current":-1.105047,"twenty":-8.929933,"median":-5.850257,"eighty":-3.629447,"marketCap":14664274},{"date":"2022-09-16","current":-1.085489,"twenty":-8.831693,"median":-5.802604,"eighty":-3.228649,"marketCap":14404729},{"date":"2022-09-23","current":-1.007256,"twenty":-8.73246,"median":-5.773542,"eighty":-3.161849,"marketCap":13366551},{"date":"2022-09-30","current":-1.07571,"twenty":-8.666305,"median":-5.743888,"eighty":-3.094827,"marketCap":14274957},{"date":"2022-10-07","current":-1.19306,"twenty":-8.533995,"median":-5.702183,"eighty":-3.02825,"marketCap":15832225},{"date":"2022-10-14","current":-1.086467,"twenty":-8.533995,"median":-5.675947,"eighty":-2.983717,"marketCap":14417706},{"date":"2022-10-21","current":-1.065931,"twenty":-8.368608,"median":-5.641175,"eighty":-2.939184,"marketCap":14145185},{"date":"2022-10-28","current":-0.745956,"twenty":-8.103988,"median":-5.574708,"eighty":-2.894651,"marketCap":9899034},{"date":"2022-11-04","current":-0.567192,"twenty":-8.037833,"median":-5.55746,"eighty":-2.872384,"marketCap":7526795},{"date":"2022-11-11","current":-0.513407,"twenty":-8.004215,"median":-5.517856,"eighty":-2.827851,"marketCap":6813047},{"date":"2022-11-18","current":-0.451599,"twenty":-7.99392,"median":-5.495807,"eighty":-2.761052,"marketCap":6877934},{"date":"2022-11-25","current":-0.416494,"twenty":-7.938335,"median":-5.469022,"eighty":-2.688237,"marketCap":6343271},{"date":"2022-12-02","current":-0.366392,"twenty":-7.856382,"median":-5.430806,"eighty":-1.257602,"marketCap":5580210},{"date":"2022-12-09","current":-0.458075,"twenty":-7.779782,"median":-5.420196,"eighty":-1.200883,"marketCap":6976560},{"date":"2022-12-16","current":-0.366392,"twenty":-7.743612,"median":-5.398191,"eighty":-1.173502,"marketCap":5580210},{"date":"2022-12-23","current":-0.30794,"twenty":-7.674473,"median":-5.355378,"eighty":-1.163722,"marketCap":4689972},{"date":"2022-12-30","current":-0.573446,"twenty":-7.610652,"median":-5.336521,"eighty":-1.150031,"marketCap":8733678},{"date":"2023-01-06","current":-0.540811,"twenty":-7.546831,"median":-5.323472,"eighty":-1.138297,"marketCap":8236650},{"date":"2023-01-13","current":-0.521469,"twenty":-7.477691,"median":-5.27995,"eighty":-1.124606,"marketCap":7942067},{"date":"2023-01-20","current":-0.582393,"twenty":-7.419189,"median":-5.261093,"eighty":-1.107003,"marketCap":8869939},{"date":"2023-01-27","current":-0.651837,"twenty":-7.312821,"median":-5.242595,"eighty":-1.095268,"marketCap":9927584},{"date":"2023-02-03","current":-0.533484,"twenty":-7.302184,"median":-5.214864,"eighty":-1.095268,"marketCap":8125046},{"date":"2023-02-10","current":-0.413256,"twenty":-7.259636,"median":-5.168494,"eighty":-1.077744,"marketCap":6293958},{"date":"2023-02-17","current":-0.545246,"twenty":-7.259636,"median":-5.139011,"eighty":-1.058107,"marketCap":8304190},{"date":"2023-02-24","current":-0.446753,"twenty":-7.259636,"median":-5.101383,"eighty":-1.017035,"marketCap":6804119},{"date":"2023-03-03","current":-0.477921,"twenty":-7.259636,"median":-5.078188,"eighty":-0.987697,"marketCap":7278825},{"date":"2023-03-10","current":-0.414545,"twenty":-7.259636,"median":-5.031261,"eighty":-0.742156,"marketCap":6313590},{"date":"2023-03-17","current":-0.336207,"twenty":-7.206452,"median":-4.969511,"eighty":-0.639737,"marketCap":5120495},{"date":"2023-03-24","current":-0.331428,"twenty":-7.206452,"median":-4.960352,"eighty":-0.630535,"marketCap":5047707},{"date":"2023-03-31","current":-0.351688,"twenty":-7.17986,"median":-4.820895,"eighty":-0.589635,"marketCap":5356266},{"date":"2023-04-06","current":-0.45174,"twenty":-7.17986,"median":-4.766672,"eighty":-0.576377,"marketCap":6880072},{"date":"2023-04-14","current":-0.359623,"twenty":-7.17986,"median":-4.653708,"eighty":-0.562385,"marketCap":6316770},{"date":"2023-04-21","current":-0.3153,"twenty":-7.158586,"median":-4.508975,"eighty":-0.54538,"marketCap":5538236},{"date":"2023-04-28","current":-0.301157,"twenty":-7.153268,"median":-4.453309,"eighty":-0.536142,"marketCap":5289807},{"date":"2023-05-05","current":-0.280887,"twenty":-7.131994,"median":-4.257226,"eighty":-0.526923,"marketCap":4933777},{"date":"2023-05-12","current":-0.26233,"twenty":-7.07881,"median":-4.141578,"eighty":-0.517222,"marketCap":4607813},{"date":"2023-05-19","current":-0.244735,"twenty":-7.033024,"median":-4.108178,"eighty":-0.502627,"marketCap":4628383},{"date":"2023-05-26","current":-0.218865,"twenty":-7.012211,"median":-4.052511,"eighty":-0.493236,"marketCap":4139139},{"date":"2023-06-02","current":-0.177519,"twenty":-7.012211,"median":-4.007978,"eighty":-0.484966,"marketCap":3357207},{"date":"2023-06-09","current":-0.429482,"twenty":-7.012211,"median":-3.952311,"eighty":-0.474116,"marketCap":8122289},{"date":"2023-06-16","current":-0.396344,"twenty":-7.012211,"median":-3.629447,"eighty":-0.464845,"marketCap":7495590},{"date":"2023-06-23","current":-0.238101,"twenty":-7.001114,"median":-3.339982,"eighty":-0.453859,"marketCap":4502917},{"date":"2023-06-30","current":-0.230481,"twenty":-6.961806,"median":-3.228649,"eighty":-0.448691,"marketCap":4358824},{"date":"2023-07-07","current":-0.2181,"twenty":-6.91394,"median":-3.195249,"eighty":-0.438648,"marketCap":4124672},{"date":"2023-07-13","current":-0.26953,"twenty":-6.91394,"median":-3.161849,"eighty":-0.429701,"marketCap":5097302},{"date":"2023-07-21","current":-0.235243,"twenty":-6.91394,"median":-3.106183,"eighty":-0.417426,"marketCap":4448882},{"date":"2023-07-28","current":-0.225719,"twenty":-6.91394,"median":-3.072783,"eighty":-0.413256,"marketCap":4268765},{"date":"2023-08-04","current":-0.17429,"twenty":-6.887347,"median":-3.050516,"eighty":-0.400475,"marketCap":3296135},{"date":"2023-08-11","current":-0.160004,"twenty":-6.887347,"median":-3.02825,"eighty":-0.38961,"marketCap":3025960},{"date":"2023-08-18","current":-0.157995,"twenty":-6.860756,"median":-2.972583,"eighty":-0.383263,"marketCap":2935902},{"date":"2023-08-25","current":-0.188589,"twenty":-6.820867,"median":-2.96145,"eighty":-0.363636,"marketCap":3504416},{"date":"2023-09-01","current":-0.158066,"twenty":-6.780979,"median":-2.939184,"eighty":-0.359623,"marketCap":2937227},{"date":"2023-09-08","current":-0.125363,"twenty":-6.780979,"median":-2.905784,"eighty":-0.354845,"marketCap":2329525},{"date":"2023-09-15","current":-0.080668,"twenty":-6.780979,"median":-2.872384,"eighty":-0.351688,"marketCap":1498998},{"date":"2023-09-22","current":-0.07597,"twenty":-6.780979,"median":-2.870157,"eighty":-0.348588,"marketCap":1411692},{"date":"2023-09-29","current":-0.062714,"twenty":-6.759705,"median":-2.827851,"eighty":-0.342044,"marketCap":1165370},{"date":"2023-10-06","current":-0.071025,"twenty":-6.754387,"median":-2.816718,"eighty":-0.335629,"marketCap":1319806},{"date":"2023-10-13","current":-0.069464,"twenty":-6.754387,"median":-2.761052,"eighty":-0.331116,"marketCap":1290799},{"date":"2023-10-20","current":-0.062018,"twenty":-6.722231,"median":-2.715542,"eighty":-0.328027,"marketCap":1152437},{"date":"2023-10-27","current":-0.064937,"twenty":-6.706276,"median":-2.682142,"eighty":-0.320027,"marketCap":1206680},{"date":"2023-11-03","current":-0.394873,"twenty":-6.674611,"median":-1.281073,"eighty":-0.325669,"marketCap":7337632},{"date":"2023-11-10","current":-0.374108,"twenty":-6.674611,"median":-1.222398,"eighty":-0.328975,"marketCap":6951778},{"date":"2023-11-17","current":-0.266701,"twenty":-6.674611,"median":-1.202839,"eighty":-0.325669,"marketCap":5225374},{"date":"2023-11-24","current":-0.246083,"twenty":-6.674611,"median":-1.19306,"eighty":-0.313052,"marketCap":4821413},{"date":"2023-12-01","current":-0.252341,"twenty":-6.648019,"median":-1.173502,"eighty":-0.301157,"marketCap":4944008},{"date":"2023-12-08","current":-0.257476,"twenty":-6.621427,"median":-1.163722,"eighty":-0.294624,"marketCap":5044616},{"date":"2023-12-15","current":-0.216613,"twenty":-6.594835,"median":-1.158832,"eighty":-0.284581,"marketCap":4244003},{"date":"2023-12-22","current":-0.21277,"twenty":-6.54165,"median":-1.144164,"eighty":-0.278188,"marketCap":4168710},{"date":"2023-12-29","current":-0.219174,"twenty":-6.54165,"median":-1.144164,"eighty":-0.276419,"marketCap":4294198},{"date":"2024-01-05","current":-0.187022,"twenty":-6.536278,"median":-1.134385,"eighty":-0.272473,"marketCap":3664249},{"date":"2024-01-12","current":-0.174212,"twenty":-6.509527,"median":-1.129495,"eighty":-0.267111,"marketCap":3413273},{"date":"2024-01-19","current":-0.034907,"twenty":-6.488466,"median":-1.124606,"eighty":-0.258101,"marketCap":683918},{"date":"2024-01-26","current":-0.245163,"twenty":-6.461874,"median":-1.105047,"eighty":-0.25511,"marketCap":4803378},{"date":"2024-02-02","current":-0.228731,"twenty":-6.461874,"median":-1.100157,"eighty":-0.252387,"marketCap":4481445},{"date":"2024-02-09","current":-0.226015,"twenty":-6.435282,"median":-1.095268,"eighty":-0.249824,"marketCap":4428227},{"date":"2024-02-16","current":-0.222025,"twenty":-6.435282,"median":-1.095268,"eighty":-0.245163,"marketCap":4350044},{"date":"2024-02-23","current":-0.243453,"twenty":-6.435282,"median":-1.085978,"eighty":-0.244479,"marketCap":4769871},{"date":"2024-03-01","current":-0.236277,"twenty":-6.414008,"median":-1.075808,"eighty":-0.242065,"marketCap":4629272},{"date":"2024-03-08","current":-0.244794,"twenty":-6.40869,"median":-1.07082,"eighty":-0.241215,"marketCap":4796151},{"date":"2024-03-15","current":-0.231347,"twenty":-6.37678,"median":-1.054196,"eighty":-0.238072,"marketCap":4532691},{"date":"2024-03-22","current":-0.228698,"twenty":-6.336892,"median":-1.014394,"eighty":-0.236326,"marketCap":4480788},{"date":"2024-03-28","current":-0.227658,"twenty":-6.312959,"median":-1.007207,"eighty":-0.235241,"marketCap":4460421},{"date":"2024-04-05","current":-0.240859,"twenty":-6.270412,"median":-0.835033,"eighty":-0.235103,"marketCap":4466991},{"date":"2024-04-12","current":-0.200193,"twenty":-6.223139,"median":-0.744056,"eighty":-0.234734,"marketCap":3712797},{"date":"2024-04-19","current":-0.157211,"twenty":-6.152029,"median":-0.657161,"eighty":-0.233326,"marketCap":2915642},{"date":"2024-04-26","current":-0.164413,"twenty":-6.116177,"median":-0.637734,"eighty":-0.231025,"marketCap":3049227},{"date":"2024-05-03","current":-0.232846,"twenty":-6.116177,"median":-0.632224,"eighty":-0.230356,"marketCap":4318393},{"date":"2024-05-10","current":-0.438028,"twenty":-6.116177,"median":-0.613536,"eighty":-0.230455,"marketCap":8123710},{"date":"2024-05-17","current":-0.316863,"twenty":-6.116177,"median":-0.589635,"eighty":-0.230455,"marketCap":5404405},{"date":"2024-05-24","current":-0.539673,"twenty":-6.100222,"median":-0.579751,"eighty":-0.230518,"marketCap":9204653},{"date":"2024-05-31","current":-0.636737,"twenty":-6.068311,"median":-0.584621,"eighty":-0.230864,"marketCap":10860166},{"date":"2024-06-07","current":-0.520261,"twenty":-6.036401,"median":-0.582393,"eighty":-0.231361,"marketCap":8873551},{"date":"2024-06-14","current":-0.45814,"twenty":-6.036401,"median":-0.573446,"eighty":-0.231448,"marketCap":7814022},{"date":"2024-06-21","current":-0.396019,"twenty":-6.036401,"median":-0.567192,"eighty":-0.231716,"marketCap":6754494},{"date":"2024-06-28","current":-0.392137,"twenty":-6.025764,"median":-0.562969,"eighty":-0.231716,"marketCap":6688273},{"date":"2024-07-05","current":-0.337043,"twenty":-5.999172,"median":-0.562107,"eighty":-0.231942,"marketCap":5748604},{"date":"2024-07-12","current":-0.37061,"twenty":-5.95387,"median":-0.549375,"eighty":-0.233157,"marketCap":6321122},{"date":"2024-07-15","current":-0.365073,"twenty":-5.951115,"median":-0.545413,"eighty":-0.233467,"marketCap":6226668},{"date":"2024-08-02","current":-0.279596,"twenty":-5.948359,"median":-0.54533,"eighty":-0.233778,"marketCap":4768774},{"date":"2024-08-09","current":-0.261577,"twenty":-5.935159,"median":-0.540811,"eighty":-0.23458,"marketCap":4461446},{"date":"2024-08-16","current":-0.241071,"twenty":-5.914078,"median":-0.535146,"eighty":-0.23458,"marketCap":4316414},{"date":"2024-08-23","current":-0.268168,"twenty":-5.887486,"median":-0.528286,"eighty":-0.2347,"marketCap":4801579},{"date":"2024-08-30","current":-0.268843,"twenty":-5.860894,"median":-0.524747,"eighty":-0.23472,"marketCap":4813665},{"date":"2024-09-06","current":-0.265178,"twenty":-5.850257,"median":-0.520013,"eighty":-0.2347,"marketCap":4748055},{"date":"2024-09-13","current":-0.243964,"twenty":-5.838208,"median":-0.51569,"eighty":-0.234714,"marketCap":4368211},{"date":"2024-09-20","current":-0.3645,"twenty":-5.813123,"median":-0.509454,"eighty":-0.234734,"marketCap":6526418},{"date":"2024-09-27","current":-0.593228,"twenty":-5.800391,"median":-0.508517,"eighty":-0.234734,"marketCap":10621832},{"date":"2024-10-04","current":-0.591107,"twenty":-5.797072,"median":-0.509454,"eighty":-0.234734,"marketCap":10583848},{"date":"2024-10-11","current":-0.70335,"twenty":-5.778248,"median":-0.513407,"eighty":-0.234801,"marketCap":12593570},{"date":"2024-10-18","current":-0.577607,"twenty":-5.747563,"median":-0.519765,"eighty":-0.235036,"marketCap":10342129},{"date":"2024-10-25","current":-0.6264,"twenty":-5.743888,"median":-0.521196,"eighty":-0.235239,"marketCap":11215771},{"date":"2024-10-31","current":-0.486,"twenty":-5.738101,"median":-0.521469,"eighty":-0.235434,"marketCap":8701891},{"date":"2024-11-08","current":-0.453214,"twenty":-5.714694,"median":-0.520013,"eighty":-0.236212,"marketCap":8114859},{"date":"2024-11-15","current":-0.337403,"twenty":-5.70907,"median":-0.51569,"eighty":-0.236289,"marketCap":6041253},{"date":"2024-11-22","current":-0.439549,"twenty":-5.690704,"median":-0.509454,"eighty":-0.236554,"marketCap":6560950},{"date":"2024-11-29","current":-0.402534,"twenty":-5.690704,"median":-0.499775,"eighty":-0.237417,"marketCap":6008448},{"date":"2024-12-06","current":-0.30495,"twenty":-5.675947,"median":-0.496415,"eighty":-0.237718,"marketCap":4551848},{"date":"2024-12-13","current":-0.252723,"twenty":-5.664112,"median":-0.493246,"eighty":-0.237958,"marketCap":3772279},{"date":"2024-12-20","current":-0.134949,"twenty":-5.64483,"median":-0.486,"eighty":-0.236338,"marketCap":2014323},{"date":"2024-12-27","current":-0.136351,"twenty":-5.638982,"median":-0.481763,"eighty":-0.235767,"marketCap":2035251},{"date":"2025-01-03","current":-0.123732,"twenty":-5.621565,"median":-0.477921,"eighty":-0.234835,"marketCap":1846899},{"date":"2025-01-10","current":-0.120227,"twenty":-5.59644,"median":-0.477553,"eighty":-0.234734,"marketCap":1794579},{"date":"2025-01-17","current":-0.117423,"twenty":-5.567922,"median":-0.472095,"eighty":-0.233467,"marketCap":1752723},{"date":"2025-01-24","current":-0.192784,"twenty":-5.557744,"median":-0.467653,"eighty":-0.231448,"marketCap":2877605},{"date":"2025-01-31","current":-0.375492,"twenty":-5.557631,"median":-0.466511,"eighty":-0.231716,"marketCap":5604804},{"date":"2025-02-07","current":-0.530353,"twenty":-5.557177,"median":-0.46549,"eighty":-0.231942,"marketCap":7916351},{"date":"2025-02-14","current":-0.497235,"twenty":-5.549313,"median":-0.466511,"eighty":-0.233157,"marketCap":7422014},{"date":"2025-02-21","current":-0.437063,"twenty":-5.517856,"median":-0.466511,"eighty":-0.234399,"marketCap":6523853},{"date":"2025-02-28","current":-0.117545,"twenty":-5.50456,"median":-0.464726,"eighty":-0.231716,"marketCap":1754547},{"date":"2025-03-07","current":-0.07883,"twenty":-5.50456,"median":-0.459919,"eighty":-0.230702,"marketCap":1176660},{"date":"2025-03-14","current":-0.034611,"twenty":-5.487055,"median":-0.45816,"eighty":-0.230267,"marketCap":516616},{"date":"2025-03-21","current":-0.035917,"twenty":-5.469524,"median":-0.455272,"eighty":-0.228053,"marketCap":536111},{"date":"2025-03-28","current":-0.813147,"twenty":-5.46852,"median":-0.454243,"eighty":-0.227692,"marketCap":12137494},{"date":"2025-04-04","current":-0.722763,"twenty":-5.46852,"median":-0.45814,"eighty":-0.227692,"marketCap":10788365},{"date":"2025-04-11","current":-0.623309,"twenty":-5.430806,"median":-0.459919,"eighty":-0.228053,"marketCap":9303856},{"date":"2025-04-17","current":-0.496779,"twenty":-5.425988,"median":-0.463616,"eighty":-0.228569,"marketCap":8323520},{"date":"2025-04-25","current":-0.55724,"twenty":-5.423723,"median":-0.459919,"eighty":-0.228724,"marketCap":9336534},{"date":"2025-05-02","current":-0.785708,"twenty":-5.418238,"median":-0.464726,"eighty":-0.228973,"marketCap":13164513},{"date":"2025-05-09","current":-0.487863,"twenty":-5.40842,"median":-0.466511,"eighty":-0.23002,"marketCap":8174135},{"date":"2025-05-16","current":-0.249953,"twenty":-5.399811,"median":-0.467234,"eighty":-0.230385,"marketCap":6377185},{"date":"2025-05-23","current":-0.248972,"twenty":-5.388064,"median":-0.465905,"eighty":-0.230022,"marketCap":6352176},{"date":"2025-05-30","current":-0.225447,"twenty":-5.378754,"median":-0.464376,"eighty":-0.228718,"marketCap":5751971},{"date":"2025-06-06","current":-0.235903,"twenty":-5.351607,"median":-0.459919,"eighty":-0.228718,"marketCap":6018729},{"date":"2025-06-13","current":-0.235413,"twenty":-5.336521,"median":-0.45814,"eighty":-0.228912,"marketCap":6006224},{"date":"2025-06-20","current":-0.228061,"twenty":-5.336521,"median":-0.455272,"eighty":-0.228316,"marketCap":5818660},{"date":"2025-06-27","current":-0.26825,"twenty":-5.333625,"median":-0.451995,"eighty":-0.228711,"marketCap":6844011},{"date":"2025-07-03","current":-0.276091,"twenty":-5.326957,"median":-0.451599,"eighty":-0.228791,"marketCap":7044080},{"date":"2025-07-11","current":-0.294062,"twenty":-5.313893,"median":-0.446753,"eighty":-0.229035,"marketCap":7502571},{"date":"2025-07-18","current":-0.328369,"twenty":-5.295036,"median":-0.443773,"eighty":-0.22914,"marketCap":8377870},{"date":"2025-07-25","current":-0.359437,"twenty":-5.27995,"median":-0.438727,"eighty":-0.229679,"marketCap":9170513},{"date":"2025-08-01","current":-0.362704,"twenty":-5.276179,"median":-0.438196,"eighty":-0.230297,"marketCap":9253881},{"date":"2025-08-08","current":-0.348,"twenty":-5.261093,"median":-0.437433,"eighty":-0.230428,"marketCap":8878723},{"date":"2025-08-15","current":-0.36107,"twenty":-5.261093,"median":-0.435462,"eighty":-0.230493,"marketCap":9212197},{"date":"2025-08-22","current":-0.319249,"twenty":-5.253694,"median":-0.433115,"eighty":-0.230574,"marketCap":7853293},{"date":"2025-08-29","current":-0.334839,"twenty":-5.223953,"median":-0.429592,"eighty":-0.230831,"marketCap":8236788},{"date":"2025-09-05","current":-0.355851,"twenty":-5.223379,"median":-0.426621,"eighty":-0.231347,"marketCap":8753671},{"date":"2025-09-12","current":-0.379574,"twenty":-5.214864,"median":-0.418933,"eighty":-0.231381,"marketCap":9337249},{"date":"2025-09-19","current":-0.380591,"twenty":-5.214864,"median":-0.417216,"eighty":-0.231655,"marketCap":9362260},{"date":"2025-09-26","current":-0.336194,"twenty":-5.189036,"median":-0.415471,"eighty":-0.231716,"marketCap":8270135},{"date":"2025-10-03","current":-0.358562,"twenty":-5.147952,"median":-0.413901,"eighty":-0.231716,"marketCap":8820366},{"date":"2025-10-10","current":-0.500903,"twenty":-5.147952,"median":-0.414143,"eighty":-0.232846,"marketCap":12321834},{"date":"2025-10-17","current":-0.505647,"twenty":-5.139011,"median":-0.415392,"eighty":-0.233289,"marketCap":12438550},{"date":"2025-10-24","current":-0.445322,"twenty":-5.136444,"median":-0.417006,"eighty":-0.234399,"marketCap":10954594},{"date":"2025-10-31","current":-0.371102,"twenty":-5.101383,"median":-0.417216,"eighty":-0.2347,"marketCap":9128828},{"date":"2025-11-07","current":-0.314843,"twenty":-5.09963,"median":-0.415471,"eighty":-0.2347,"marketCap":7744915},{"date":"2025-11-14","current":-0.285359,"twenty":-5.083853,"median":-0.414344,"eighty":-0.234734,"marketCap":7019610},{"date":"2025-11-21","current":-0.263004,"twenty":-5.072524,"median":-0.413256,"eighty":-0.234734,"marketCap":7136326},{"date":"2025-11-28","current":-0.313948,"twenty":-5.067562,"median":-0.411836,"eighty":-0.234734,"marketCap":8518632},{"date":"2025-12-05","current":-0.291836,"twenty":-5.038273,"median":-0.403424,"eighty":-0.234734,"marketCap":7918660},{"date":"2025-12-12","current":-0.352135,"twenty":-4.996097,"median":-0.40212,"eighty":-0.234868,"marketCap":9554806},{"date":"2025-12-19","current":-0.265284,"twenty":-4.980397,"median":-0.400432,"eighty":-0.23517,"marketCap":7198198},{"date":"2025-12-26","current":-0.251091,"twenty":-4.967679,"median":-0.398908,"eighty":-0.235241,"marketCap":6813072},{"date":"2026-01-02","current":-0.230813,"twenty":-4.960352,"median":-0.396262,"eighty":-0.234801,"marketCap":6262850},{"date":"2026-01-09","current":-0.267986,"twenty":-4.960352,"median":-0.395503,"eighty":-0.235024,"marketCap":7271508},{"date":"2026-01-16","current":-0.2984,"twenty":-4.925606,"median":-0.392535,"eighty":-0.235219,"marketCap":8096774},{"date":"2026-01-23","current":-0.314959,"twenty":-4.86998,"median":-0.391393,"eighty":-0.235238,"marketCap":8546085},{"date":"2026-01-30","current":-0.354076,"twenty":-4.841932,"median":-0.390649,"eighty":-0.235277,"marketCap":9607469},{"date":"2026-02-06","current":-0.336926,"twenty":-4.782328,"median":-0.389903,"eighty":-0.23551,"marketCap":9142111},{"date":"2026-02-13","current":-0.333884,"twenty":-4.76765,"median":-0.389142,"eighty":-0.235899,"marketCap":9059584},{"date":"2026-02-20","current":-0.350781,"twenty":-4.76504,"median":-0.388794,"eighty":-0.235903,"marketCap":9518065},{"date":"2026-02-27","current":-0.343684,"twenty":-4.740785,"median":-0.38547,"eighty":-0.236196,"marketCap":9325503},{"date":"2026-03-06","current":-0.315297,"twenty":-4.653708,"median":-0.38427,"eighty":-0.236277,"marketCap":8555255},{"date":"2026-03-13","current":-0.331181,"twenty":-4.609175,"median":-0.383567,"eighty":-0.236338,"marketCap":8986227},{"date":"2026-03-20","current":-0.314622,"twenty":-4.542375,"median":-0.383263,"eighty":-0.237417,"marketCap":8536916},{"date":"2026-03-27","current":-0.2886,"twenty":-4.475575,"median":-0.381152,"eighty":-0.237718,"marketCap":7830855},{"date":"2026-04-02","current":-0.293669,"twenty":-4.471122,"median":-0.379597,"eighty":-0.23791,"marketCap":7968399},{"date":"2026-04-10","current":-0.28894,"twenty":-4.456649,"median":-0.3794,"eighty":-0.238072,"marketCap":7840076},{"date":"2026-04-17","current":-0.230161,"twenty":-4.440562,"median":-0.378211,"eighty":-0.238072,"marketCap":7977621},{"date":"2026-04-24","current":-0.229367,"twenty":-4.300841,"median":-0.375938,"eighty":-0.236326,"marketCap":7950112},{"date":"2026-05-01","current":-0.211907,"twenty":-4.101497,"median":-0.374432,"eighty":-0.235379,"marketCap":7344913},{"date":"2026-05-08","current":-0.202383,"twenty":-3.972352,"median":-0.37178,"eighty":-0.234868,"marketCap":7014805},{"date":"2026-05-15","current":-0.186123,"twenty":-3.803126,"median":-0.369434,"eighty":-0.234714,"marketCap":6451220},{"date":"2026-05-22","current":-0.143979,"twenty":-3.513661,"median":-0.366392,"eighty":-0.233733,"marketCap":5811096},{"date":"2026-05-29","current":-0.124554,"twenty":-3.339982,"median":-0.365679,"eighty":-0.231934,"marketCap":5027097},{"date":"2026-06-05","current":-0.137504,"twenty":-3.331075,"median":-0.364787,"eighty":-0.231354,"marketCap":5549763},{"date":"2026-06-12","current":-0.133972,"twenty":-3.282089,"median":-0.364324,"eighty":-0.230493,"marketCap":5407218}],"updateTime":1781563305929},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640590262","title":"TransCode Says Phase 1a Cancer Trial Meets Safety Goal, Advances Drug to Phase 2a","url":"https://stock-news.laohu8.com/highlight/detail?id=2640590262","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640590262?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:04","pubTimestamp":1780491877,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics  said Wednesday that its Phase 1a dose-escalation trial of cancer therapy TTX-MC138 met its primary safety endpoint, with no dose-limiting toxicities observed across 16 patients treated.The company said 9 of 14 evaluable patients, or 64%, achieved stable disease lasting at least six months. Three patients remain on treatment, with one receiving therapy for 21 cycles, it added.TTX-MC138, an investigational inhibitor of microRNA-10b, is being developed to target metastatic cancer. TransCode said it selected 4.8 mg/kg as the recommended Phase 2a dose and plans to evaluate the therapy in patients with circulating tumor DNA-positive colorectal cancer following curative-intent treatment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901171","title":"TransCode Therapeutics reports Phase 1a trial of TTX-MC138 meets safety endpoint in metastatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901171","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901171?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:07","pubTimestamp":1780488424,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics completed a Phase 1a dose-escalation trial of TTX-MC138 in metastatic cancer, clearing its safety objective.Patients generally tolerated treatment, with no dose-limiting toxicities reported, supporting a move into Phase 2a development.Several participants achieved durable disease stabilization, including some who remain on therapy.Future scientific congress presentations are planned; a clinical study report is being prepared.Phase 2a will evaluate TTX-MC138 in ctDNA-positive colorectal cancer following curative-intent therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on June 03, 2026, and is solely r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL7DfZ32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901995","title":"Transcode Therapeutics - Ttx-Mc138 Advances to Phase 2a Clinical Development in Ctdna-Positive Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901995?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:04","pubTimestamp":1780488240,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1LZP5V:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901961","title":"Transcode Therapeutics - Phase 1a Trial Meets Safety Endpoint With No Dose-Limiting Toxicities","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901961?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:04","pubTimestamp":1780488240,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1LZP5V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640019699","title":"Transcode Therapeutics - Recommended Phase 2a Dose for Ttx-Mc138 Set at 4.8Mg/Kg","url":"https://stock-news.laohu8.com/highlight/detail?id=2640019699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640019699?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:04","pubTimestamp":1780488240,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1LZP5V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904149","title":"EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904149","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904149?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:41","pubTimestamp":1780486860,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics announced successful completion of Phase 1a clinical trial for TTX-MC138, showing safety and disease stabilization in patients with advanced cancer.","market":"us","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,dpr=2,format=auto,quality=85/files/images/story/2026/06/03/Cancer---Heart-Shape-To-Represent-Medica.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,dpr=2,format=auto,quality=85/files/images/story/2026/06/03/Cancer---Heart-Shape-To-Represent-Medica.jpeg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/06/52965529/exclusive-transcodes-rna-therapeutic-achieves-64-stable-disease-rate-in-colorectal-cancer-phase-1-study","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/06/52965529/exclusive-transcodes-rna-therapeutic-achieves-64-stable-disease-rate-in-colorectal-cancer-phase-1-study","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","BK4588","IE0009354923.USD","BK4505","RNA","BK4539","RNAZ","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640952277","title":"TransCode Sets Key Deadlines for 2026 Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640952277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640952277?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:36","pubTimestamp":1780320993,"startTime":"0","endTime":"0","summary":"The latest announcement is out from TransCode Therapeutics ( ($RNAZ) ). TransCode Therapeutics said it plans to hold its 2026 annual meeting of sto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-sets-key-deadlines-for-2026-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-sets-key-deadlines-for-2026-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640199954","title":"TransCode Therapeutics sets 2026 annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640199954","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640199954?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:00","pubTimestamp":1780318847,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics will hold its 2026 annual meeting of stockholders on July 2, 2026, in Boston.Stockholders will vote on matters to be presented at the annual meeting, including director nominations submitted for consideration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL19zDgR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638891656","title":"Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138","url":"https://stock-news.laohu8.com/highlight/detail?id=2638891656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638891656?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:31","pubTimestamp":1779892266,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (RNAZ) announced the initiation of its Phase 2a clinical trial. The study is to evaluate TransCode’s lead therapeutic candid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-initiates-phase-2a-clinical-trial-with-ttx-mc138-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-initiates-phase-2a-clinical-trial-with-ttx-mc138-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","RNAZ","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507033","title":"TransCode Therapeutics launches Phase 2a trial of TTX-MC138 in ctDNA-positive colorectal cancer patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507033","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507033?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:07","pubTimestamp":1779883632,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics launched a Phase 2a trial of TTX-MC138 in ctDNA-positive colorectal cancer patients following curative-intent therapy.Results have not been presented; the study is expected to generate future data on recurrence-risk reduction in minimal residual disease.Trial targets up to 45 patients with no radiographic disease but persistent or new ctDNA positivity, a marker of residual cancer risk.Study runs with Quantum Leap Healthcare Collaborative on the PRE-I-SPY platform, expanding access to established oncology trial sites.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL33GtkT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638750729","title":"Transcode Therapeutics Initiates Phase 2a Clinical Trial With Ttx-Mc138 in Patients With Ctdna Positive Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2638750729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638750729?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:04","pubTimestamp":1779883440,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA1SJPPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637475063","title":"TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2637475063","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637475063?lang=en_us&edition=fundamental","pubTime":"2026-05-23 06:10","pubTimestamp":1779487852,"startTime":"0","endTime":"0","summary":"An update from TransCode Therapeutics ( ($RNAZ) ) is now available. On May 19, 2026, TransCode Therapeutics disclosed that it received a deficiency...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-receives-nasdaq-listing-deficiency-notice?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-receives-nasdaq-listing-deficiency-notice?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","RNAZ","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637434434","title":"TransCode Therapeutics falls short of Nasdaq $2.5 million stockholders' equity requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2637434434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637434434?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:17","pubTimestamp":1779481051,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics received a Nasdaq deficiency notice on May 19, 2026 for failing to meet the Nasdaq Capital Market’s minimum stockholders’ equity rule.Stockholders’ equity was $1,251,427 as of the quarter ended March 31, 2026, below the $2,500,000 required under Listing Rule 5550.The notice does not trigger an immediate delisting, but the company must submit a compliance plan by July 3, 2026.Nasdaq may grant up to a 180-day extension to regain compliance; failure to secure acceptance or regain compliance could lead to a delisting determination, subject to appeal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL21KqrN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635559840","title":"TransCode Therapeutics Q1 EPS $(21.28) Up From $(70.16) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635559840","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635559840?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:43","pubTimestamp":1778884997,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(21.28) per share. This is a 69.67 percent increase over losses of $(70.16) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620544/transcode-therapeutics-q1-eps-21-28-up-from-70-16-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TransCode Therapeutics Q1 EPS $(21.28) Up From $(70.16) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635377250","title":"TransCode Therapeutics Q1 FY26 net loss widens to $17.79 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635377250","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635377250?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:17","pubTimestamp":1778876258,"startTime":"0","endTime":"0","summary":"Transcode Therapeutics posted a net loss of USD 17.79 million for the three months ended March 31, 2026, widening from USD 12.09 million a year earlier.Operating loss widened to USD 17.76 million from USD 3.17 million, as total operating expenses climbed to USD 17.76 million from USD 3.17 million.Research and development expense rose to USD 5.11 million from USD 2.22 million, while acquired in-process research and development expense was USD 10.43 million.Cash totaled about USD 12.8 million at quarter-end; cash used in operating activities increased to USD 4.98 million from USD 3.1 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL1fY0ZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467230","title":"TransCode Therapeutics announces virtual special shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467230?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:22","pubTimestamp":1778275328,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics will hold a virtual special stockholder meeting in 2026 to seek approval for potential issuances of common stock tied to several financing and strategic transactions.Vote will cover conversion of Series A Non-Voting Convertible Preferred Stock and Series B Non-Voting Convertible Preferred Stock into common stock, representing up to 14,658,055 shares on an as-converted basis.Stockholders will also vote on conversion of Series C Non-Voting Convertible Preferred Stock into common stock, representing up to 1,214,204 shares.Another proposal seeks authorization for potential issuance of common stock under standby equity purchase agreement with YA II PN, LTD and related Convertible Notes, beyond an existing 183,301-share cap.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDLST1vH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632484856","title":"TransCode Registers 1.53 Million Shares for YA II PN Resale Under Equity Purchase Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2632484856","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632484856?lang=en_us&edition=fundamental","pubTime":"2026-05-01 22:43","pubTimestamp":1777646608,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics  filed a resale registration Thursday covering up to 1.53 million shares that YA II PN Ltd may sell from time to time.YA II PN, also known as Yorkville, is the counterparty to the company's standby equity purchase agreement signed April 6, according to the preliminary prospectus filed with regulators.The shares include 750,000 issuable upon conversion of convertible notes, 750,000 that may be issued through advances under the agreement, and 33,334 commitment shares. TransCode said it has received $950,000 from the sale of a convertible note and may receive up to $18.8 million more from additional note sales and share issuances under the facility.TransCode will not receive proceeds from the selling stockholder's resale of the registered shares.Price: 8.40, Change: +0.39, Percent Change: +4.87","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","RNAZ","BK4215","EQR","BK4585","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632629316","title":"Transcode Therapeutics files to sell 15.96M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2632629316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632629316?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:30","pubTimestamp":1777584652,"startTime":"0","endTime":"0","summary":"17:27 EDT Transcode Therapeutics (RNAZ) files to sell 15.96M shares of common stock for holders Published first on TheFly – the ultimate source for...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-files-to-sell-15-96m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-files-to-sell-15-96m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","RNAZ","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632664097","title":"Transcode Therapeutics - Files for Resale of up to About 16 Mln Common Shares by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2632664097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632664097?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:27","pubTimestamp":1777584439,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41D1SG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396609","title":"Transcode Therapeutics Appoints DR. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement With Michigan State University","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396609?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:02","pubTimestamp":1777291320,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUACZ9SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}